Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹373Cr
Floriculture/Tissue Culture
Rev Gr TTM
Revenue Growth TTM
25.14%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NATHBIOGEN
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 65.3 | 12.4 | 3.9 | 25.4 | -4.3 | 3.7 | 42.6 | 16.2 | 20.8 | 16.3 | 36.2 | 78.9 |
| 41 | 198 | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 245 | 38 | 62 |
Operating Profit Operating ProfitCr |
| 8.8 | 15.7 | 22.1 | 17.8 | 9.1 | 15.0 | 15.0 | 21.8 | 0.8 | 13.5 | 13.9 | 5.4 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 4 | 4 |
Interest Expense Interest ExpenseCr | 2 | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 2 | 34 | 2 | 2 | 2 | 34 | 1 | 4 | 2 | 36 | 5 | 2 |
| 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
|
Growth YoY PAT Growth YoY% | 101.2 | 8.6 | 2.0 | 183.0 | 81.9 | -0.1 | -26.0 | -30.6 | -43.5 | 11.8 | 334.2 | -39.6 |
| 3.2 | 14.2 | 6.7 | 12.0 | 6.1 | 13.7 | 3.5 | 7.2 | 2.9 | 13.1 | 11.0 | 2.4 |
| 0.8 | 17.6 | 0.9 | 2.0 | 1.9 | 17.5 | 0.5 | 1.3 | 0.4 | 19.6 | 2.5 | 0.8 |
| Financial Year | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 11.1 | | 8.3 | 10.4 | 9.7 | 22.1 |
| 108 | 118 | 241 | 253 | 283 | 315 | 397 |
Operating Profit Operating ProfitCr |
| 13.0 | 14.4 | 13.4 | 16.2 | 15.0 | 13.7 | 10.9 |
Other Income Other IncomeCr | 1 | 1 | -87 | 1 | 4 | 5 | 14 |
Interest Expense Interest ExpenseCr | 2 | 4 | 11 | 10 | 9 | 10 | 13 |
Depreciation DepreciationCr | 5 | 5 | 3 | 3 | 3 | 4 | 4 |
| 9 | 12 | -63 | 36 | 42 | 41 | 45 |
| 0 | 1 | 4 | 1 | 2 | 2 | 3 |
|
| | 27.7 | | 152.0 | 13.2 | -2.6 | 17.1 |
| 7.4 | 8.5 | -24.2 | 11.6 | 11.9 | 10.6 | 10.1 |
| 5.8 | 7.3 | -35.5 | 18.4 | 21.3 | 20.1 | 23.4 |
| Financial Year | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 16 | 16 | 19 | 19 | 19 | 19 | 19 |
| 30 | 41 | 523 | 554 | 591 | 625 | 661 |
Current Liabilities Current LiabilitiesCr | 72 | 98 | 194 | 216 | 262 | 365 | 317 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 3 | 3 | 3 | 8 | 17 | 18 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 96 | 120 | 468 | 521 | 572 | 690 | 706 |
Non Current Assets Non Current AssetsCr | 24 | 39 | 272 | 272 | 309 | 336 | 308 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 14 | 17 | 38 | 75 | 18 |
Investing Cash Flow Investing Cash FlowCr | -21 | -20 | -3 | -27 | -4 |
Financing Cash Flow Financing Cash FlowCr | 6 | -22 | -2 | -8 | -2 |
|
Free Cash Flow Free Cash FlowCr | -7 | 16 | 36 | 48 | 10 |
| 121.0 | -25.3 | 109.6 | 188.3 | 45.5 |
CFO To EBITDA CFO To EBITDA% | 71.4 | 45.8 | 78.7 | 149.6 | 35.3 |
| Financial Year | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 405 | 269 | 330 | 277 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 7.7 | 8.3 | 7.2 |
Price To Sales Price To Sales | 0.0 | 0.0 | 1.5 | 0.9 | 1.0 | 0.8 |
Price To Book Price To Book | 0.0 | 0.0 | 0.8 | 0.5 | 0.5 | 0.4 |
| 0.3 | 0.8 | 13.3 | 6.9 | 7.3 | 6.2 |
Profitability Ratios Profitability Ratios |
| 96.9 | 101.4 | 96.9 | 94.3 | 102.7 | 124.7 |
| 13.0 | 14.4 | 13.4 | 16.2 | 15.0 | 13.7 |
| 7.4 | 8.5 | -24.2 | 11.6 | 11.9 | 10.6 |
| 19.9 | 21.1 | -8.3 | 6.8 | 7.0 | 6.7 |
| 20.1 | 20.4 | -12.4 | 6.1 | 6.5 | 6.0 |
| 7.7 | 7.4 | -9.1 | 4.4 | 4.5 | 3.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Profile**
Nath Bio-Genes (India) Ltd (NBIL) is a leading Indian seed technology company with over three decades of experience in agricultural innovation. Specializing in hybrid and genetically modified (GM) seeds, the company serves as a key enabler of India’s transition toward high-yield, climate-resilient, and sustainable agriculture. With a science-led approach, NBIL develops genetically pure, premium-quality seeds and integrated farm productivity solutions for field crops, vegetables, and plant nutrition.
The company is publicly listed and operates as a pan-India, multi-crop, and multi-product organization, with strategic international operations underway.
---
### **Core Business & Product Portfolio**
NBIL operates in three primary verticals:
1. **Hybrid and GM Seeds** – For cotton, hybrid paddy, maize, bajra (pearl millet), wheat, mustard, and vegetable crops (tomato, okra, chili, cucumber, etc.).
2. **Plant Nutrition Solutions (PNS)** – High-margin products such as **Win-Chi-Win**, soil conditioners (e.g., Windrow GOLii, Winhall Granules), and biotonic supplements (e.g., WINPro GOLii, WINall Granules).
3. **Integrated Seed Technology & Agronomic Support** – Farmer education, crop demonstrations, and extension programs.
**Flagship Products**:
- **Cotton**: *Sanket*, *Nath Jumbo*, *RANA* – top-ranked in ICAR trials, with 200–250 bolls per plant (vs. 130–150 for competitors).
- **Paddy**: *Loknath*, *Gorakhnath*, *Dhadak*, *Dhadak Gold* – developed for early maturity, fine grain quality, and resistance to Bacterial Leaf Blight (BLB) and Brown Planthopper (BPH).
- **Vegetables**: *Tomato Akhand* (virus-resistant, all-season hybrid), *Super-27 Bajra*, and *Hybrid Chili Rana*.
- **Plant Nutrition**: *Win-Chi-Win* – foliar spray with 70%+ gross margins.
---
### **Research & Development (R&D)**
- **DSIR-Recognized Innovation Centers**: Supported by a team of experienced scientists, plant breeders, and biotechnologists.
- **R&D Investment**: INR 10–12 crores annually (4–5% of revenue), with a 7–10 year innovation cycle.
- **R&D Infrastructure**:
- 40+ breeding and evaluation stations across 325 acres in diverse agro-climatic zones.
- Proprietary germplasm collection with trait-specific resistance to pests, diseases, drought, and heat.
- Focus on molecular marker-assisted breeding (e.g., DNA tech for rice and tomato) alongside conventional methods.
- **Collaborations**: Partners with global institutions – NRCPB, ICRISAT, CIMMYT, IRRI.
- **Innovation Pipeline**:
- Next-gen cotton hybrids with pink bollworm and sucking pest resistance, medium-to-large boll size, and wide adaptability.
- Heat-tolerant tomato variety (*North Akhand*) capable of growth at 47°C.
- Disease-resistant okra and tomato with dual resistance markers.
---
### **Production & Infrastructure**
- **Seed Production**:
- Over 30,000 acres under contracted cultivation with 25,000+ growers.
- 10 processing plants, 17 branch offices across 23 Indian states.
- Key facilities in **Chhatrapati Sambhajinagar (Maharashtra)** and **Munipalli, Nizamabad (Telangana)**.
- **Storage & Logistics**:
- 25,000 MT capacity in cold storage, conditioning godowns, and warehouses.
- Asset-light model with long-term leases for operational efficiency.
- **Quality Control**:
- Over **200,000 annual seed quality tests** for genetic purity, germination, and compliance.
- Adheres to national traceability and certification standards (e.g., ICAR, state seed boards).
---
### **Market Performance & Growth Drivers (as of Nov 2025)**
- **Cotton Seeds**:
- H1 FY26 volume: **1.11 million packets** (+6% YoY), value up **26.3%** due to premium hybrids.
- Flagship brands *Sanket* and *Jumbo* dominate with high farmer retention and yield superiority.
- Despite illegal RRF BT seed presence, NBIL remains resilient due to product performance.
- **Paddy**:
- Stable base revenue; strategic shift toward **high-margin hybrid paddy**.
- *Dhadak* and *Dhadak Gold* show strong market traction.
- **Maize**:
- Double-digit growth in FY25 due to favorable agro-climatic conditions and hybrid adoption.
- **Vegetable Seeds**:
- **Fastest-growing segment** – 60% value growth in FY25.
- *Akhand Tomato* and *Super-27 Bajra* are key success stories.
- Pipeline includes virus-resistant okra and improved gourd varieties.
- **Plant Nutrition Solutions (PNS)**:
- Sustained double-digit growth; **Win-Chi-Win sales up 34% in FY24**.
- Expansion into bio-organic additives to support soil health.
---
### **Diversification & Strategic Focus**
NBIL is executing **Strategy 4.0** to de-risk its business and build long-term resilience:
1. **Reduce Crop Concentration**:
- Target to limit any single crop’s revenue share to **<25%**.
- Cotton and paddy previously accounted for ~59% (down from 65% in past).
2. **Non-Cotton, Non-Paddy (NCP) Growth**:
- NCP segment reached **48% of total revenue (INR 171 crores)** in FY25, up from 43%.
- Maize (+47%), Bajra (+66%), Wheat (+36% value), and Mustard are core growth drivers.
3. **Operational Efficiency**:
- Debtor days reduced from 120–130 to **88 days** in 3–4 years.
- Focus on working capital optimization and inventory management.
4. **R&D-Led Differentiation**:
- Prioritizing high-margin, patented hybrids with superior performance and resistance.
---
### **Geographic Expansion & International Ventures**
- **Uzbekistan (Flagship JV)**:
- **Nath Bio-Genes (Central Asia) LLC**, 90% owned, based in Samarkand.
- 600-hectare cotton production in first full year; contribution-level break-even achieved.
- Government-backed land and infrastructure; future plans for proprietary BT cotton launch.
- **Philippines**:
- BT gene approved; hybrids demonstrated successfully.
- Preparing for **commercial sales to government agencies** in upcoming season.
- **Africa**:
- Active trials in Sudan, Egypt, and Myanmar.
- Expansion delayed in some regions due to geopolitical instability.
- **Global Strategy**:
- Assessing markets in Africa, Southeast Asia, and the Middle East.
- Focus on geographies with climatic similarity to India.
- Export presence in Bangladesh, Egypt, Myanmar.
---
### **Distribution & Farmer Engagement**
- **Domestic Network**:
- **20,000+ distributors and dealers** across 131 regions in 23 states.
- 400+ **Nath Farm Advisors (NFAs)** providing on-ground support.
- Farmer education programs, crop demonstrations, and seasonal training.
- **Feedback Loop**:
- Customizes products based on **farmer needs and agro-climatic data**.
- Crop patterns: Kharif (cotton, maize, paddy); Rabi (wheat, mustard, vegetables).
- **Direct-to-Farmer Initiatives**:
- Exploring direct retail expansion to reach 20,000+ retail outlets.
- Urban gardening focus in metro areas like Mumbai.
---
### **Key Competitive Advantages**
- **Product Superiority**: Industry-leading cotton hybrids with **200–250 bolls per plant**, disease resistance, and low input costs.
- **R&D Scale**: Proprietary germplasm, long-term partnerships, and global R&D recognition.
- **Market Intelligence**: Deep understanding of regional agronomy and cropping cycles.
- **Integrated Model**: Seed + nutrient + advisory = holistic farm productivity solution.
- **Brand Trust**: Sanket and Jumbo are **top 3 in ICAR trials**; strong farmer loyalty.